Is CYP24A1 Heterozygosity a Risk Factor for Nephrolithiasis?

Not yet recruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

October 1, 2026

Study Completion Date

April 1, 2028

Conditions

Nephrolithiasis

Interventions

BIOLOGICAL

Supplementary blood samples for PBMC analysis at V2

Supplementary blood (serum and plasma) and urines samples for bio collection at V3

Trial Locations (2)

Hôpital Femme Mère Enfant, Bron

Hôpital Edouard Herriot, Lyon

All Listed Sponsors

lead

Hospices Civils de Lyon

OTHER